Drug Device Combination Products Market Size, Share & Trends Analysis Report by Product (Transdermal Patches, Infusion Pumps, Inhalers, Drug Eluting Stents), Region, and Segment Forecasts, 2024-2030

The global drug device combination products market size is expected to reach USD 251.87 billion by 2030, registering a CAGR of 9.0% from 2024 to 2030. Rising demand for minimally invasive techniques due to enhanced patient outcomes associated with it is the high impact-rendering driver of this market. These devices facilitate early diagnosis and reduce treatment duration in a majority of surgical procedures. Growing demand is also a consequence of minimal pain, heightened cost efficiency, improved safety, better efficacy, rapid recovery, and reduced hospital stay rendered by these devices.

Increasing presence of regulatory healthcare authorities enforcing clearly defined protocols for premarket authorizations is anticipated to support manufacturers in gaining approvals for their products. Recently, the U.S. FDA incorporated the lean management process mapping approach to build a more cohesive, streamlined, systematic, and collaborative system for the review of the aforementioned products. Safety guidelines and recommendations issued by these authorities are presumed to increase the adoption of these products in future and boost overall growth during the forecast period.

Severe side effects and drug interactions associated with therapeutics owing to drug absorption by unintended sites in the body are anticipated to induce need for targeted therapy, thereby propelling demand for drug-device combinations. For instance, consistent administration of Levodopa results in long-term complications such as motor fluctuations, dyskinesias, severe metabolic changes, and neurotoxic effects. These aforementioned factors drive the clinical urgency to incorporate alternatives based on targeted therapy, as in case of drug-device combination products.

Drug Device Combination Products Market Report Highlights

Transdermal patch held the dominant share by product in 2023 owing to increasing demand for self-administration of drugs in diseases requiring long-term treatment
North America held the largest share of over 41.31% in 2023 in terms of region owing to extensive new product development activities conducted by prominent players across this region
Asia Pacific is anticipated to grow at a lucrative rate over the coming years owing to increasing healthcare spending and rising awareness levels of physicians pertaining to benefits of these products
Key market players are engaged in various strategies such as new product launch and distribution agreements to gain market penetration
High operational cost, stringent regulatory framework, and capital requirement keep entry barriers at a higher level, owing to which, threat of new entrants is expected to be low.

Chapter 1. Methodology and Scope

1.1. Market Segmentation
1.2. Market Definition
1.2.1. Product
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. List of Secondary Sources
1.9. List of Abbreviations
1.10. Objectives
1.10.1. Objectives 1
1.10.2. Objectives 2
1.10.3. Objectives 3

Chapter 2. Executive Summary

2.1. Market Snapshot (Regional)
2.2. Segment Snapshot (Product)
2.3. Competitive Landscape

Chapter 3. Drug Device Combination Products Market Variables, and Trends

3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Impact Analysis
3.2.1.1. Increasing Demand for Minimally Invasive Drug Delivery Devices
3.2.1.2. Technological Advancements
3.2.1.3. Increasing Prevalence of Chronic Diseases
3.2.2. Market Restraint Impact Analysis
3.2.2.1. High Cost Associated with Drug Device Combination Products
3.2.2.2. Technical Challenges in Drug Delivery
3.2.2.3. Increasing Prevalence of Chronic Diseases
3.2.3. Market Opportunity Impact Analysis
3.2.3.1. Growing Adherence Rate
3.3. Industry Analysis Tools
3.3.1. Porter’s Analysis
3.3.2. Macroeconomics Analysis

Chapter 4. Drug Device Combination Product Market: Product Analysis

4.1. Product Movement Analysis & Market Share, 2023
4.2. Drug Device Combination Products Market: Estimates & Forecast, by Product (USD Billion)
4.2.1. Infusion Pumps
4.2.1.1. Infusion Pumps Market, 2018-2030 (USD Million)
4.2.1.2. Volumetric
4.2.1.2.1. Volumetric Market, 2018-2030 (USD Million)
4.2.1.3. Disposables
4.2.1.3.1. Disposables Market, 2018-2030 (USD Million)
4.2.1.4. Syringes
4.2.1.4.1. Syringes Market, 2018-2030 (USD Million)
4.2.1.5. Ambulatory
4.2.1.5.1. Ambulatory Market, 2018-2030 (USD Million)
4.2.1.6. Implantable
4.2.1.6.1. Implantable Market, 2018-2030 (USD Million)
4.2.1.7. Insulin
4.2.1.7.1. Insulin Market, 2018-2030 (USD Million)
4.2.2. Orthopedic Combination Products
4.2.2.1. Orthopedic Combination Product Market, 2018-2030 (USD Million)
4.2.2.2. Bone Graft Implants
4.2.2.2.1. Bone Graft Implant Market, 2018-2030 (USD Million)
4.2.2.3. Antibiotic Bone Cement
4.2.2.3.1. Antibiotic Bone Cement Market, 2018-2030 (USD Million)
4.2.3. Photodynamics Therapy Devices
4.2.3.1. Photodynamics Therapy Devices Market, 2018-2030 (USD Million)
4.2.4. Transdermal Patches
4.2.4.1. Transdermal Patches Market, 2018-2030 (USD Million)
4.2.5. Drug Eluting Stents
4.2.5.1. Drug Eluting Stents Market, 2018-2030 (USD Million)
4.2.5.2. Coronary Stents
4.2.5.2.1. Coronary Stents Market, 2018-2030 (USD Million)
4.2.5.3. Peripheral Vascular Stents
4.2.5.3.1. Peripheral Vascular Stents Market, 2018-2030 (USD Million)
4.2.6. Wound Care Products
4.2.6.1. Wound Care Product Market, 2018-2030 (USD Million)
4.2.7. Inhalers
4.2.7.1. Inhalers Market, 2018-2030 (USD Million)
4.2.7.2. Dry Powder
4.2.7.2.1. Dry Powder Market, 2018-2030 (USD Million)
4.2.7.3. Nebulizers
4.2.7.3.1. Nebulizers Market, 2018-2030 (USD Million)
4.2.7.4. Metered Dose
4.2.7.4.1. Metered Dose Market, 2018-2030 (USD Million)
4.2.8. Antimicrobial Catheters
4.2.8.1. Antimicrobial Catheters Market, 2018-2030 (USD Million)
4.2.8.2. Urological
4.2.8.2.1. Urological Market, 2018-2030 (USD Million)
4.2.8.3. Cardiovascular
4.2.8.3.1. Cardiovascular Market, 2018-2030 (USD Million)
4.2.8.4. Others
4.2.8.4.1. Others Market, 2018-2030 (USD Million)
4.2.9. Others
4.2.9.1. Others Market, 2018-2030 (USD Million)

Chapter 5. Drug Device Combination Products Market: Regional Estimates & Trend Analysis

5.1. Drug Device Combination Products Market: Regional Outlook
5.2. North America
5.2.1. North America Drug Device Combination Products Market Estimates and Forecast, 2018-2030 (USD Million)
5.2.2. U.S.
5.2.2.1. Key Country Dynamics
5.2.2.2. Competitive Scenario
5.2.2.3. Regulatory Scenario
5.2.2.4. Reimbursement Scenario
5.2.2.5. U.S. Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
5.2.3. Canada
5.2.3.1. Key Country Dynamics
5.2.3.2. Competitive Scenario
5.2.3.3. Regulatory Scenario
5.2.3.4. Reimbursement Scenario
5.2.3.5. Canada Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
5.3. Europe
5.3.1. Europe Drug Device Combination Products Market Estimates and Forecast, 2018-2030 (USD Million)
5.3.2. Germany
5.3.2.1. Key Country Dynamics
5.3.2.2. Competitive Scenario
5.3.2.3. Regulatory Scenario
5.3.2.4. Reimbursement Scenario
5.3.2.5. Germany Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
5.3.3. UK
5.3.3.1. Key Country Dynamics
5.3.3.2. Competitive Scenario
5.3.3.3. Regulatory Scenario
5.3.3.4. Reimbursement Scenario
5.3.3.5. UK Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
5.3.4. France
5.3.4.1. Key Country Dynamics
5.3.4.2. Competitive Scenario
5.3.4.3. Regulatory Scenario
5.3.4.4. Reimbursement Scenario
5.3.4.5. France Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
5.4. Asia-Pacific
5.4.1. Asia-Pacific Drug Device Combination Products Market Estimates and Forecast, 2018-2030 (USD Million)
5.4.2. Japan
5.4.2.1. Key Country Dynamics
5.4.2.2. Competitive Scenario
5.4.2.3. Regulatory Scenario
5.4.2.4. Reimbursement Scenario
5.4.2.5. Japan Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
5.4.3. China
5.4.3.1. Key Country Dynamics
5.4.3.2. Competitive Scenario
5.4.3.3. Regulatory Scenario
5.4.3.4. Reimbursement Scenario
5.4.3.5. China Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
5.4.4. India
5.4.4.1. Key Country Dynamics
5.4.4.2. Competitive Scenario
5.4.4.3. Regulatory Scenario
5.4.4.4. Reimbursement Scenario
5.4.4.5. India Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
5.4.5. Australia
5.4.5.1. Key Country Dynamics
5.4.5.2. Competitive Scenario
5.4.5.3. Regulatory Scenario
5.4.5.4. Reimbursement Scenario
5.4.5.5. Australia Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
5.4.6. South Korea
5.4.6.1. Key Country Dynamics
5.4.6.2. Competitive Scenario
5.4.6.3. Regulatory Scenario
5.4.6.4. Reimbursement Scenario
5.4.6.5. South Korea Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5. Latin America
5.5.1. Latin America Drug Device Combination Products Market Estimates and Forecast, 2018-2030 (USD Million)
5.5.2. Brazil
5.5.2.1. Key Country Dynamics
5.5.2.2. Competitive Scenario
5.5.2.3. Regulatory Scenario
5.5.2.4. Reimbursement Scenario
5.5.2.5. Brazil Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
5.5.3. Mexico
5.5.3.1. Key Country Dynamics
5.5.3.2. Competitive Scenario
5.5.3.3. Regulatory Scenario
5.5.3.4. Reimbursement Scenario
5.5.3.5. Mexico Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
5.6. Middle East & Africa
5.6.1. Middle East & Africa Drug Device Combination Products Market Estimates and Forecast, 2018-2030 (USD Million)
5.6.2. South Africa
5.6.2.1. Key Country Dynamics
5.6.2.2. Competitive Scenario
5.6.2.3. Regulatory Scenario
5.6.2.4. Reimbursement Scenario
5.6.2.5. South Africa Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
5.6.3. Saudi Arabia
5.6.3.1. Key Country Dynamics
5.6.3.2. Competitive Scenario
5.6.3.3. Regulatory Scenario
5.6.3.4. Reimbursement Scenario
5.6.3.5. Saudi Arabia Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
5.6.4. UAE
5.6.4.1. Key Country Dynamics
5.6.4.2. Competitive Scenario
5.6.4.3. Regulatory Scenario
5.6.4.4. Reimbursement Scenario
5.6.4.5. UAE Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
5.6.5. Kuwait
5.6.5.1. Key Country Dynamics
5.6.5.2. Competitive Scenario
5.6.5.3. Regulatory Scenario
5.6.5.4. Reimbursement Scenario
5.6.5.5. Kuwait Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)

Chapter 6. Competitive Analysis

6.1. Company Categorization
6.2. Participant Overview
6.3. Financial Performance
6.4. Product Benchmarking
6.5. Company Market: Position Analysis
6.6. Strategy Mapping
6.6.1. Mergers & Acquisitions
6.6.2. Partnerships & Collaborations
6.6.3. Product Launch & Regulatory Approval
6.6.4. Expansion
6.7. Company Profiles
6.7.1. Abbott
6.7.1.1. Company Overview
6.7.1.2. Financial Performing
6.7.1.3. Product Benchmarking
6.7.1.4. Strategic Initiatives
6.7.2. Terumo Medical Corporation
6.7.2.1. Company Overview
6.7.2.2. Financial Performing
6.7.2.3. Product Benchmarking
6.7.2.4. Strategic Initiatives
6.7.3. Stryker
6.7.3.1. Company Overview
6.7.3.2. Financial Performing
6.7.3.3. Product Benchmarking
6.7.3.4. Strategic Initiatives
6.7.4. Viatris Inc.
6.7.4.1. Company Overview
6.7.4.2. Financial Performing
6.7.4.3. Product Benchmarking
6.7.4.4. Strategic Initiatives
6.7.5. Medtronic
6.7.5.1. Company Overview
6.7.5.2. Financial Performing
6.7.5.3. Product Benchmarking
6.7.5.4. Strategic Initiatives
6.7.6. Boston Scientific Corporation
6.7.6.1. Company Overview
6.7.6.2. Financial Performing
6.7.6.3. Product Benchmarking
6.7.6.4. Strategic Initiatives
6.7.7. Novartis AG
6.7.7.1. Company Overview
6.7.7.2. Financial Performing
6.7.7.3. Product Benchmarking
6.7.7.4. Strategic Initiatives
6.7.8. Becton
6.7.8.1. Company Overview
6.7.8.2. Financial Performing
6.7.8.3. Product Benchmarking
6.7.8.4. Strategic Initiatives
6.7.9. Dickinson and Company
6.7.9.1. Company Overview
6.7.9.2. Financial Performing
6.7.9.3. Product Benchmarking
6.7.9.4. Strategic Initiatives
6.7.10. Teleflex Incorporation
6.7.10.1. Company Overview
6.7.10.2. Financial Performing
6.7.10.3. Product Benchmarking
6.7.10.4. Strategic Initiatives

Chapter 7. Analysis Perspective

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Drug Device Combination Products Market Revenue Estimates and Forecast, by Product, 2018-2030 (USD Billion)
Table 4 U.S. Regulatory Procedure for Medical Devices
Table 5 Canada Regulatory Procedure for Medical Devices
Table 6 Classification of Medical Devices

List of Figures

Figure 1 Drug Device Combination Products Market Segmentation
Figure 2 Market Research Process
Figure 3 Information Procurement
Figure 4 Primary Research Pattern
Figure 5 Market Research Approaches
Figure 6 Value Chain-based Sizing & Forecasting
Figure 7 Market Formulation & Validation
Figure 8 Market Snapshot, USD Million
Figure 9 Segment Snapshot (Product)
Figure 10 Competitive Landscape
Figure 11 Drug Delivery Devices and Drug Device Combination Products Market Value, 2023 (USD Million)
Figure 12 Drug Device Combination Products Market Dynamics
Figure 13 Diabetes Around the World in 2021, (Million)
Figure 14 Estimated Number of U.S. Hospital Hip and Knee Replacement Procedures: (2021-2022)
Figure 15 Drug Device Combination Products Market: PORTER’s Analysis
Figure 16 Drug Device Combination Products Market: PESTEL Analysis
Figure 17 Drug Device Combination Product Market: Product Outlook and Key Takeaways
Figure 18 Drug Device Combination Products Market, by Product: Market Share, 2023 & 2030
Figure 19 Infusion Pumps Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 20 Volumetric Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 21 Disposables Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 22 Syringes Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 23 Ambulatory Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 24 Implantable Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 25 Insulin Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 26 Orthopedic Combination Products Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 27 Bone Graft Implants Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 28 Antibiotic Bone Cement Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 29 Photodynamic Therapy Devices Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 30 Transdermal Patches Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 31 Drug Eluting Stents Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 32 Coronary Stents Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 33 Peripheral Vascular Stents Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 34 Wound Care Products Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 35 Inhalers Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 36 Dry Powder Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 37 Nebulizers Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 38 Metered Dose Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 39 Antimicrobial Catheters Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 40 Urological Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 41 Cardiovascular Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 42 Others Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 43 Others Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 44 Drug Device Combination Products Market Revenue, by Region, 2023 & 2030 (USD Billion)
Figure 45 Regional Marketplace: Key Takeaways
Figure 46 North America Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 47 Key Country Dynamics
Figure 48 Reimbursement Procurement Process
Figure 49 US Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 50 Key Country Dynamics
Figure 51 Canada Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 52 Europe Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 53 Key Country Dynamics
Figure 54 Germany Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 55 Key Country Dynamics
Figure 56 UK Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 57 Key Country Dynamics
Figure 58 France Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 59 Asia-Pacific Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 60 Key Country Dynamics
Figure 61 Reimbursement Procurement Process
Figure 62 Japan Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 63 Key Country Dynamics
Figure 64 China Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 65 Key Country Dynamics
Figure 66 India Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 67 Key Country Dynamics
Figure 68 Australia Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 69 Key Country Dynamics
Figure 70 South Korea Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 71 Latin America Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 72 Key Country Dynamics
Figure 73 Brazil Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 74 Key Country Dynamics
Figure 75 Mexico Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 76 Middle East & Africa Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 77 Key Country Dynamics
Figure 78 South Africa Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 79 Key Country Dynamics
Figure 80 Saudi Arabia Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 81 Key Country Dynamics
Figure 82 UAE Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 83 Key Country Dynamics
Figure 84 Kuwait Drug Device Combination Products Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 85 Key Company Categorization
Figure 86 Company Market Position Analysis
Figure 87 Strategy Mapping

Companies Mentioned

Abbott
Terumo Medical Corporation
Stryker
Viatris Inc.
Medtronic
Boston Scientific Corporation
Novartis AG
Becton
Dickinson and company
Teleflex Incorporation

Table Information

Report Attribute	Details
No. of Pages	150
Published	May 2024
Forecast Period	2023 - 2030
Estimated Market Value ( USD ) in 2023	$ 138.47 Billion
Forecasted Market Value ( USD ) by 2030	$ 251.87 Billion
Compound Annual Growth Rate	9.0%
Regions Covered	Global
No. of Companies Mentioned	10

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5247EUR$5,950USD£4,526GBP
1 - 5 USER LICENSE PDF	The product is a PDF.	This is a 1-5 user license, allowing up to five users have access to the product.	€6129EUR$6,950USD£5,287GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€7893EUR$8,950USD£6,808GBP

Drug Device Combination Products Market Report Highlights

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Drug-Device Combination Products Market by Product Type, Technology, Dosage Form, Therapeutic Class, End-User - Global Forecast to 2030

Drug Device Combination Products Market by Type (Injectable, Transdermal Patch, Infusion Pump, Drug-eluting Stent, Inhaler), Application (Diabetes, Oncology, Pain, Opthamology), End User (Hospital, Home Care), and Region - Global Forecast to 2030

Drug Eluting Stent Market by Type, Drug, Application, End User, Distribution Channel - Global Forecast to 2030

Drug Device Combination Products Market Report by Product, Application, End User, and Region 2024-2032

Drug Device Combination Products - Global Strategic Business Report